UConn R&D is in the process of soliciting funding and recruiting management for several projects. These include:

Cornovus Pharmaceuticals
Dr. Bruce Liang, Director of the Pat and Jim Calhoun Cardiology Center, in conjunction with the National Institutes of Health, has identified a new target and class of agents to treat cardiac failure. The technology, which has been proven in mouse models, delays the onset of heart failure after a heart attack or injury. The project has been awarded $75,000 for conducting canine studies. The tests are being conducted at New York Medical College, which has extensive experience working with canine models.

Contact UConn R&D for more information on current projects seeking funding and management.